Published July 31, 2019 | Version v1
Journal article Open

CONCENTRATIONS OF CYSTEINYL LEUKOTRIENES IN VARIOUS BIOLOGICAL FLUIDS OF CHILDREN WITH BRONCHIAL ASTHMA, ATOPIC DERMATITIS AND FOOD PROTEIN INDUCED ENTEROCOLITIS

Creators

  • 1. State Institution "Institute Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of NAMS of Ukraine"

Description

Clinical manifestation of food allergy is characterized by polymorphic cutaneous, respiratory and gastrointestinal syndromes. Leukotrienes occupy a key place in the pathogenesis of a wide range of inflammatory diseases, including bronchial asthma, allergic rhinitis, atopic dermatitis, hives, allergic conjunctivitis, atherosclerotic cardio-vascular lesions system, inflammatory bowel disease, multiple sclerosis, cancer, etc. Better understanding of general pathophysiological mechanisms of allergic realization put the focus on the studying of cysteinyl leukotrienes biological effects in infants with atopic dermatitis and food-protein induced enterocolitis important.

Aim. To optimize the diagnosis of allergic lesions of the gastrointestinal tract in children.

Methods. The study was conducted in the allergy center and children clinic of the «Institute Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of NAMS of Ukraine». Children were included from September 2017 to June 2018.

We examined 60 patients aged from 3 months to 3 years old, including 22 patients with atopic dermatitis, 18 children with food-protein induced enterocolitis, 8 patients with bronchial asthma in the stage of aggravation and 12 practically healthy children (control group).

Medical examination have been perfomed, general IG E and specific serum IG E were defined by ImmunoCAP (Phadia, 100), as well as concentrations of cysteinyl leukotrienes (LTB4, LTC4, LTE4) in biological liquids (serum, saliva, urine) using immunoenzyme method using the production sets of the "Enzolifescience" (USA) company on the analyzer-photometer Multiskan Plus "Labsystems". The results of the received data were processed statistically. The probability of differences was estimated with Student’s t-test and Tau Kendall rank correlation test. The difference was considered significant at p <0.05.

Results. A significant increase in the concentrations of cysteinyl leukotrienes (C4, D4, E4) in the blood, urine and saliva was found in infants with allergic skin diseases, gastro-intestinal and respiratory tract surveyed during manifestation the disease compared with the control group.

Comparison of concentrations of leukotrienes in urine and saliva of children with atopic dermatitis (AD), food-protein induced enterocolitis (FPIE) and asthma did not find credible. However, in the serum of patients with asthma, the concentration of cysteinyl leukotrienes was significantly higher (703.9±68.7) pg / ml than in children with enterocolitis induced by dietary proteins (509.3±57.4) pg / ml and significantly did not differ from patients with atopic dermatitis (695.2±46.3) pg / ml.

According to the results of Kendall Tau correlation test, no significant Spearman rank correlation was found between the cysteinyl leukotrienes concentration in blood and urine – r=0.14 (p>0.05), blood and saliva r=0.07 (p>0.05), urine and saliva r=–0.52 (p>0.05).

Conclusions. Increase in cysteinyl leukotrienes concentrations in serum, urine and saliva of children of early age with allergic skin diseases, respiratory and gastrointestinal tract was found. The absence of significant Spearman rank correlation between concentrations of leukotrienes in blood and urine, blood and saliva, saliva and urine shows that it is possible to select any biological fluid, saliva or urine, as a non-invasive way to determine the leukotriene concentrations for monitoring activity of allergic inflammation.

Files

CONCENTRATIONS OF CYSTEINYL LEUKOTRIENES IN VARIOUS BIOLOGICAL FLUIDS OF CHILDREN WITH BRONCHIAL ASTHMA, ATOPIC DERMATITIS AND FOOD PROTEIN INDUCED ENTEROCOLITIS.pdf

Files (367.3 kB)

Additional details

References

  • Koletzko, S., Niggemann, B., Arato, A., Dias, J. A., Heuschkel, R., Husby, S. et. al. (2012). Diagnostic Approach and Management of Cowʼs-Milk Protein Allergy in Infants and Children. Journal of Pediatric Gastroenterology and Nutrition, 55 (2), 221–229. doi: http://doi.org/10.1097/mpg.0b013e31825c9482
  • Berin, M. C., Sampson, H. A. (2013). Food allergy: an enigmatic epidemic. Trends in Immunology, 34 (8), 390–397. doi: http://doi.org/10.1016/j.it.2013.04.003
  • Maloney, J., Nowak -Wegrzyn, А. (2014). Educational clinical case series for pediatric allergy and immunology: Allergic proctocolitis, food protein-induced enterocolitis syndrome and allergic eosinophilic gastroenteritis with protein-losing gastroenteropathy as manifestations of non-IgE-mediated cow's milk allergy. Journal of Pediatric Allergy and Immunology, 18 (4), 360–367. doi: http://doi.org/10.1111/j.1399-3038.2007.00561.x
  • Waserman, S., Bégin, P., Watson, W. (2018). IgE-mediated food allergy. Allergy, Asthma & Clinical Immunology, 14 (S2). doi: http://doi.org/10.1186/s13223-018-0284-3
  • Macharadze, D. (2013). Clinical features of food allergy in children. Pediatrics, 92 (3), 110–116. Available at: https://pediatriajournal.ru/files/upload/mags/329/2013_3_3714.pdf
  • Nowak-Węgrzyn, A., Chehade, M., Groetch, M. E., Spergel, J. M., Wood, R. A., Allen, K. et. al. (2017). International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary–Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology. Journal of Allergy and Clinical Immunology, 139 (4), 1111–1126. doi: http://doi.org/10.1016/j.jaci.2016.12.966
  • Sicherer, S. (2013). Clinical aspects of gastrointestinal food allergy in childhood. Pediatrics, 111 (6), 1609–1616.
  • Boyce, J. A. (2007). Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunological Reviews, 217 (1), 168–185. doi: http://doi.org/10.1111/j.1600-065x.2007.00512.x
  • Pelz, B. J., Wechsler, J. B., Amsden, K., Johnson, K., Singh, A. M., Wershil, B. K. et. al. (2016). IgE-associated food allergy alters the presentation of paediatric eosinophilic esophagitis. Clinical & Experimental Allergy, 46 (11), 1431–1440. doi: http://doi.org/10.1111/cea.12776
  • El-Ghoneimy, D., El-Sayed, Z. (2014). Leukotrienes and leukotriene modifiers in pediatric allergic diseases. Egyptian Journal of Pediatric Allergy and Immunology, 12 (1), 3–12. Available at: http://www.jespai.org/cms/upload/1395779928.pdf
  • Papadopoulos, N. G., Arakawa, H., Carlsen, K.-H., Custovic, A., Gern, J., Lemanske, R. et. al. (2012). International consensus on (ICON) pediatric asthma. Allergy, 67 (8), 976–997. doi: http://doi.org/10.1111/j.1398-9995.2012.02865.x
  • Rothenberg, M. E. (2004). Eosinophilic gastrointestinal disorders (EGID). Journal of Allergy and Clinical Immunology, 113 (1), 11–28. doi: http://doi.org/10.1016/j.jaci.2003.10.047
  • Galli, S. J., Grimbaldeston, M., Tsai, M. (2008). Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nature Reviews Immunology, 8 (6), 478–486. doi: http://doi.org/10.1038/nri2327
  • Meyer, R., Fleming, C., Dominguez-Ortega, G., Lindley, K., Michaelis, L., Thapar, N. et. al. (2013). Manifestations of food protein induced gastrointestinal allergies presenting to a single tertiary paediatric gastroenterology unit. World Allergy Organization Journal, 6, 13. doi: http://doi.org/10.1186/1939-4551-6-13
  • Global strategy for asthma management and prevention (2015). National institutes of health. National Heart, lung and Blood Institute. Available at: http://www.ginasthma.org
  • Scaparrotta, A., Di Pillo, S., Attanasi, M., Rapino, D., Cingolani, A., Consilvio, N. P. et. al. (2012). Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma. Multidisciplinary Respiratory Medicine, 7 (1), 1–9. doi: http://doi.org/10.1186/2049-6958-7-13
  • Buck, M. (2015). Montelukast: a review of recent studies in pediatric asthma and allergic rhinitis. Pediatric Pharmacology, 21 (4). Available at: http://www.medscape.com/viewarticle/845468
  • Pei, A. Y. S., Chan, H. H. L., Leung, T. F. (2001). Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: A pilot study. Pediatric Allergy and Immunology, 12 (3), 154–158. doi: http://doi.org/10.1034/j.1399-3038.2001.012003154.x
  • Oh, J., Lee, H. (2004). Study of urinary leukotriene E4 and serum eosinophil cationic protein in children with atopic dermatitis and their correlation with disease activity. Journal of Allergy and Clinical Immunology, 113 (2), S56. doi: http://doi.org/10.1016/j.jaci.2003.12.165
  • Gupta, S. K., Peters-Golden, M., Fitzgerald, J. F., Croffie, J. M., Pfefferkorn, M. D., Molleston, J. P. et. al. (2006). Cysteinyl Leukotriene Levels in Esophageal Mucosal Biopsies of Children with Eosinophilic Inflammation: Are They All the Same? The American Journal of Gastroenterology, 101 (5), 1125–1128. doi: http://doi.org/10.1111/j.1572-0241.2006.00557.x